Geneva Capital Management LLC Has $2.11 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Geneva Capital Management LLC increased its stake in Intuitive Surgical by 15% by acquiring an additional 553 shares, bringing their total holdings to 4,251 shares valued at approximately $2.1 million.
• Insiders from Intuitive Surgical recently sold a significant number of shares, with CEO Gary S. Guthart selling 2,800 shares and EVP Myriam Curet selling 4,500 shares, indicating a decrease in their ownership positions.
• Several analysts have raised their price targets for Intuitive Surgical, with recommendations ranging from "buy" to "neutral," and the average consensus price target now sits at approximately $595.95.

Geneva Capital Management LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,251 shares of the medical equipment provider's stock after purchasing an additional 553 shares during the quarter. Geneva Capital Management LLC's holdings in Intuitive Surgical were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of ISRG. Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 7.7% in the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after buying an additional 295,025 shares during the period. Northern Trust Corp boosted its stake in shares of Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares during the period. Capital Research Global Investors boosted its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares during the period. GAMMA Investing LLC boosted its stake in shares of Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after buying an additional 3,022,979 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Intuitive Surgical by 12.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock valued at $1,475,566,000 after buying an additional 319,694 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,903 shares of company stock worth $7,932,778. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.1%

NASDAQ ISRG traded up $0.27 during mid-day trading on Friday, reaching $470.08. 1,445,546 shares of the company's stock traded hands, compared to its average volume of 2,319,941. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a fifty day simple moving average of $516.52 and a 200-day simple moving average of $529.35. The company has a market cap of $168.51 billion, a price-to-earnings ratio of 65.56, a P/E/G ratio of 4.92 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ISRG. BTIG Research raised their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Piper Sandler reissued an "overweight" rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Finally, Evercore ISI raised their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.